The Journal of Immunology, Vol 154, Issue 2 511-519, Copyright © 1995 by American Association of Immunologists

ARTICLES

Presentation of endogenous and exogenous antigens is not affected by inactivation of E1 ubiquitin-activating enzyme in temperature-sensitive cell lines

JH Cox, P Galardy, JR Bennink and JW Yewdell
Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD 20892.

Little is known regarding the mechanism by which MHC class I-associated peptides are generated. Proteins can be targeted for degradation by the covalent attachment of ubiquitin. The first step in ubiquitin conjugation to proteins is its binding to E1 ubiquitin-activating enzyme. To study the role of ubiquitin-targeted protein degradation in Ag processing, we used two mutant cell lines with temperature-sensitive E1 proteins, and a recombinant vaccinia virus expressing wild-type human E1. One of the cell lines examined (hamster ts20 cells) was previously reported to have a minimal capacity after a 1-h incubation at 41 degrees C to present osmotically loaded OVA to a T cell hybridoma, as assessed by IL-2 release. Even after incubating the same cells for 1 h at 43 degrees C, we failed to detect an E1-related decrease in the presentation of biosynthesized or osmotically loaded OVA to splenic T cells, as measured by target cell lysis. We introduce the use of mouse tsA1S9 cells to Ag-processing studies and provide the initial biochemical characterization of their defect in protein ubiquitination. Relative to parental L929 cells, after thermal inactivation of E1, these cells actually demonstrate enhanced presentation of endogenous or exogenous viral Ags to T cells. Our findings do not support a role for protein ubiquitination in Ag processing, and indicate that either the temperature-sensitive cell lines examined do not exhibit a sufficient reduction in ubiquitin- conjugating activity to affect the generation of antigenic peptides, or that ubiquitin-targeted proteolysis is not essential for processing the two exogenous and six endogenous Ags examined.

This article has been cited by other articles:

				Y. Yang, J. Kitagaki, R.-M. Dai, Y. C. Tsai, K. L. Lorick, R. L. Ludwig, S. A. Pierre, J. P. Jensen, I. V. Davydov, P. Oberoi, et al. Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics Cancer Res., October 1, 2007; 67(19): 9472 - 9481. [Abstract] [Full Text] [PDF]

				S.-B. Qian, M. F. Princiotta, J. R. Bennink, and J. W. Yewdell Characterization of Rapidly Degraded Polypeptides in Mammalian Cells Reveals a Novel Layer of Nascent Protein Quality Control J. Biol. Chem., January 6, 2006; 281(1): 392 - 400. [Abstract] [Full Text] [PDF]

				H. N. LODE, N. HUEBENER, Y. ZENG, S. FEST, S WEIXLER, and G. GAEDICKE DNA Minigene Vaccination for Adjuvant Neuroblastoma Therapy Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 113 - 121. [Abstract] [Full Text] [PDF]

				D. E. Ott, L. V. Coren, R. C. Sowder II, J. Adams, and U. Schubert Retroviruses Have Differing Requirements for Proteasome Function in the Budding Process J. Virol., March 15, 2003; 77(6): 3384 - 3393. [Abstract] [Full Text] [PDF]

				R. Shringarpure, T. Grune, J. Mehlhase, and K. J. A. Davies Ubiquitin Conjugation Is Not Required for the Degradation of Oxidized Proteins by Proteasome J. Biol. Chem., January 3, 2003; 278(1): 311 - 318. [Abstract] [Full Text] [PDF]

				C. J. Luckey, J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors J. Immunol., August 1, 2001; 167(3): 1212 - 1221. [Abstract] [Full Text] [PDF]

				C. J. Luckey, G. M. King, J. A. Marto, S. Venketeswaran, B. F. Maier, V. L. Crotzer, T. A. Colella, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Proteasomes Can Either Generate or Destroy MHC Class I Epitopes: Evidence for Nonproteasomal Epitope Generation in the Cytosol J. Immunol., July 1, 1998; 161(1): 112 - 121. [Abstract] [Full Text] [PDF]

				L. C. Anton, H. L. Snyder, J. R. Bennink, A. Vinitsky, M. Orlowski, A. Porgador, and J. W. Yewdell Dissociation of Proteasomal Degradation of Biosynthesized Viral Proteins from Generation of MHC Class I-Associated Antigenic Peptides J. Immunol., May 15, 1998; 160(10): 4859 - 4868. [Abstract] [Full Text] [PDF]

				U. Schubert, L. C. Anton, J. H. Cox, S. Bour, J. R. Bennink, M. Orlowski, K. Strebel, and J. W. Yewdell CD4 Glycoprotein Degradation Induced by Human Immunodeficiency Virus Type 1 Vpu Protein Requires the Function of Proteasomes and the Ubiquitin-Conjugating Pathway J. Virol., March 1, 1998; 72(3): 2280 - 2288. [Abstract] [Full Text] [PDF]

				Q. Deveraux, S. van Nocker, D. Mahaffey, R. Vierstra, and M. Rechsteiner Inhibition of Ubiquitin-mediated Proteolysis by the Arabidopsis 26 S Protease Subunit S5a J. Biol. Chem., December 15, 1995; 270(50): 29660 - 29663. [Abstract] [Full Text] [PDF]

				M. Groettrup, T. Ruppert, L. Kuehn, M. Seeger, S. Standera, U. Koszinowski, and P. M. Kloetzel The Interferon-[IMAGE]-inducible 11 S Regulator (PA28) and the LMP2/LMP7 Subunits Govern the Peptide Production by the 20 S Proteasome in Vitro J. Biol. Chem., October 6, 1995; 270(40): 23808 - 23815. [Abstract] [Full Text] [PDF]

				A. Orian, S. Whiteside, A. Israël, I. Stancovski, A. L. Schwartz, and A. Ciechanover Ubiquitin-mediated Processing of NF-kappaB Transcriptional Activator Precursor p105 J. Biol. Chem., September 15, 1995; 270(37): 21707 - 21714. [Abstract] [Full Text] [PDF]

				N. P. N. Emmerich, A. K. Nussbaum, S. Stevanovic, M. Priemer, R. E. M. Toes, H.-G. Rammensee, and H. Schild The Human 26 S and 20 S Proteasomes Generate Overlapping but Different Sets of Peptide Fragments from a Model Protein Substrate J. Biol. Chem., July 7, 2000; 275(28): 21140 - 21148. [Abstract] [Full Text] [PDF]